Importance Schizophrenia is associated with an increased risk of type 2 diabetes. However,
it is not clear whether schizophrenia confers an inherent risk for glucose dysregulation in the …

There is a growing body of research focused on the relationship between childhood trauma
and the risk of develo** psychosis. Numerous studies, including many large-scale …

Background Schizophrenia might share intrinsic inflammatory disease pathways with type 2
diabetes. We aimed to assess whether first-episode psychosis, which could be described as …

Background The extent of metabolic and lipid changes in first-episode psychosis (FEP) is
unclear. Aims To investigate whether individuals with FEP and no or minimal antipsychotic …

Background Dyslipidaemia is one of the most prevalent metabolic disturbances observed in
schizophrenia patients and has been largely attributed to the effects of poor lifestyle habits …

Background Nonalcoholic fatty disease (NAFLD) is the most common liver disease, since it
is strongly associated with obesity and metabolic syndrome pandemics. NAFLD may affect …

Background Some studies have suggested that antipsychotic-naïve patients with
nonaffective psychosis (NAP) have glucose intolerance. Aims To conduct a systematic …

For decades, there have been observations demonstrating significant metabolic
disturbances in people with schizophrenia including clinically relevant weight gain …

Disturbance of glucose metabolism may be implicated in cognitive deficits of schizophrenia
in its early phases. Many studies have reported the important role of widespread disruption …

Objective Schizophrenia is associated with abnormal neuroimmunoendocrine function.
There is evidence for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in individuals …